New evidence on coronary revascularization in TAVI setting from the REVASC-TAVI Registry: should we pospone PCI after TAVI? EuroIntervention eurointervention.pcronline.com/article/compar…

In the international REVASC-TAVI registry, among patients with severe aortic stenosis and stable CAD scheduled for TAVI, PCI "after" the aortic intervention was associated with better 2-year outcomes compared with other revascularisation timing strategies. eurointervention.pcronline.com/article/compar…

Seems an exciting and under-discussed paper out in JACC Journals LBBB pacing outperforming Biventricular pacing is massive! Assuming #EPeeps can move toward this broadly, is BiV CRT necessary any longer? jacc.org/doi/10.1016/j.…

Read this study from the #NEOPRO registries now on JACC Journals 💡New PPI after TAVR is associated w/ higher 1-year mortality 💡This is particularly evident if LVEF <40% 🌐 doi.org/10.1016/j.jcin… MPagnesi antonio mangieri Azeem Latib Montefiore Heart

In patients with severe AS and stable CAD scheduled for TAVI, performance of PCI after TAVI seems to be associated with improved 2-year clinical outcomes compared with other revascularisation timing strategies. ow.ly/5Jlc50PiHOI

In the OPERA-TAVI registry, matched patients undergoing TAVI using Evolut PRO/PRO+ and Sapien 3 ULTRA devices exhibited comparable rates of the composite endpoint of all-cause mortality, rehospitalisation for heart failure, or disabling stroke at 1 year. eurointervention.pcronline.com/article/one-ye…

SIMULTANEOUS PUBLICATION #PCRLV In this registry, patients undergoing TAVI using PRO and ULTRA devices exhibited comparable rates of the composite endpoint of all-cause mortality, rehospitalisation for HF, or disabling stroke at 1 year. Read more 👉ow.ly/VfLm50Q9e11

1-year outcomes OPERA-TAVI registry finally out! 👉 No differences in mortality and re-hosp 👉Higher disabling stroke in Evolut PRO/PRO+ (2.6% vs. 0.4%). Selection bias? Real THV effect? It is time for more RCTs! #TAVI EuroIntervention Giuliano Costa eurointervention.pcronline.com/article/one-ye…

What you should know about the OPERA-#TAVI registry just published in EuroIntervention and presented at #PCRLV 2023! 🎥 Chiara De Biase interviewed first author Giuliano Costa

#PCRLV 2023 may be over, but the #science is here to stay⭐️ If busy again back home, here a handy overview of the results of the presented #TopLateBreakers ⤵️ Presented by: Philipp Lurz G.Nickenig, P.Nicz, Lukas Stolz G.Costa

x.com/JEscaned/statu… Davide Capodanno PCRonline 🫀

In the RE-ACCESS 2 Study unsuccessful coronary cannulation after #Evolut and #Acurate implanted with commissural alignment was 5.5%. Acurate still better than Evolut, but Remarkable improvement compared with RE-ACCESS.Commissural alignment in #TAVI matters JACC Journals

💥TAVR in Small Annuli: SAPIEN ULTRA vs. Evolut PRO JACC Journals 🌐A SMART Trial-like design in a Real-World TAVR Registry 🔗 doi.org/10.1016/j.jcin… Azeem Latib @MatteoMSturla GCosta Marco Barbanti Montefiore Health System Albert Einstein College of Medicine - Official ⏳ What will the SMART RCT show American College of Cardiology?

Self-expanding (SE) Evolut PRO vs balloon-expandable (BE) SAPIEN ULTRA in small annuli: 🔸 SE - superior hemodynamic performance (gradients, PPM) 🔸 BE - less PVL, PPI, stroke 📎 bit.ly/3vntMHB #JACCINT #vhdAS #TAVI

"RE-ACCESS 2" study reveals insights into coronary cannulation post-TAVR with self-expanding devices. 5.5% faced issues, mainly with Evolut THVs. Commissural alignment crucial! bit.ly/3vwb9l6 #JACCINT #Cardiology #TAVR #cvCAD

This propensity-score matched study may be a foretaste of the SMART trial that will be presented at ACC this week. Evolut PRO and SAPIEN ULTRA Performance in Small Aortic Annuli: The OPERA-TAVI Registry | JACC: Cardiovascular Interventions jacc.org/doi/10.1016/j.…

A special day for me, my first Roland Garros semifinal, and to reach the ranking of world #1. Grateful for this moment, something we have worked very hard for, but the work doesn’t stop here, forza!!! 1️⃣🦊

Is there a simplified left atrial appendage closure pathway? Safety and efficacy of percutaneous closure without preprocedural imaging. A Research Letter Giuliano Costa george ramsay Claudio Sanfilippo Marco Barbanti #cardiotwitter #AHAJournals ahajrnls.org/3XDBKZb

Severe aortic wall thrombus is a strong predictor of embolic event and #stroke in transfemoral #TAVR #JACCINT Marc Bonnet Harbaoui Brahim